Open-label Extension Study for CLCZ696G2301 (PARADISE-MI)
Condition(s):Post Myocardial InfarctionLast Updated:November 26, 2021Withdrawn
Hide Studies Not Open or Pending
Condition(s):Post Myocardial InfarctionLast Updated:November 26, 2021Withdrawn
Condition(s):Sacubitril/Valsartan; Hypertension; ObesityLast Updated:August 8, 2023Recruiting
Condition(s):Essential Hypertension; High Blood PressureLast Updated:April 19, 2012Completed
Condition(s):HealthyLast Updated:October 7, 2015Completed
Condition(s):Myocardial Infarction; HypertensionLast Updated:September 29, 2021Unknown status
Condition(s):Acute Heart FailureLast Updated:November 21, 2019Completed
Condition(s):PheochromocytomaLast Updated:September 1, 2021Completed
Condition(s):Systemic Lupus Erythematosus; LupusLast Updated:December 24, 2013Completed
Condition(s):Breast Feeding; Hypertension; Heart Failure; ProteinuriaLast Updated:October 18, 2023Recruiting
Condition(s):Chronic Kidney DiseaseLast Updated:September 15, 2016Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.